1-157683244-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_052939.4(FCRL3):c.1811G>A(p.Gly604Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0012 in 1,613,424 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052939.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCRL3 | NM_052939.4 | c.1811G>A | p.Gly604Glu | missense_variant, splice_region_variant | 11/15 | ENST00000368184.8 | NP_443171.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCRL3 | ENST00000368184.8 | c.1811G>A | p.Gly604Glu | missense_variant, splice_region_variant | 11/15 | 1 | NM_052939.4 | ENSP00000357167.3 |
Frequencies
GnomAD3 genomes AF: 0.000749 AC: 114AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000578 AC: 145AN: 250714Hom.: 0 AF XY: 0.000531 AC XY: 72AN XY: 135504
GnomAD4 exome AF: 0.00125 AC: 1825AN: 1461190Hom.: 3 Cov.: 31 AF XY: 0.00120 AC XY: 869AN XY: 726898
GnomAD4 genome AF: 0.000749 AC: 114AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.000685 AC XY: 51AN XY: 74418
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.1811G>A (p.G604E) alteration is located in exon 11 (coding exon 10) of the FCRL3 gene. This alteration results from a G to A substitution at nucleotide position 1811, causing the glycine (G) at amino acid position 604 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at